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implant failure rates in a community-based cohort.
Methods: Study population: Female participants in the General Practice
Research Database undergoing a TKA or THA from 1986 to 2006 were
included. Revision surgery was identiﬁed using READ codes. In order to
identify arthroplasties indicated for osteoarthritis, we excluded patients
aged <40 years at the date of surgery, and those with a history of either
previous hip fracture or rheumatoid arthritis.
Exposure: Women with at least 6 prescriptions of HRT or 6 months on
therapy with a high (>80%) adherence were identiﬁed as HRT users. Three
sensitivity analyses were carried out, where we explored the association
between HRT use for12 months, HRT adherence and cumulative use, and
time to failure. We used time varying Cox Models to account for the
immortal time till met deﬁnition of HRT use.
Statistical analysis: Time-varying Cox models were used to estimate hazard
ratios (HR) for HRT users versus non-users matched by propensity score to
minimize for confounding by indication. Potential confounders were: age,
gender, body mass index, joint replaced (hip/knee), year of surgery, OA
indication, fracture history, anti-osteoporosis medication use, oral gluco-
corticoids, smoking, alcohol intake, multiple deprivation index, UK region,
co-morbid conditions, and use of drugs which can affect bone metabolism.
Results: Of 24,733 eligible women included, 3,644 met the deﬁnition of
HRT user and the remaining 21,089 were non-users. From the propensity-
matching, 2,700 HRT users and 3 comparable controls (8,100women)were
selected. The median (interquartile range) follow-up was 3.3 (1.5-6.1)
years after surgery. Despite matching, HRT users were more likely to be
taking drugs with increase fracture risk.
A total of 168 (1.56%) participants underwent revision surgery during the
period of followup. The cumulative failure rate was signiﬁcantly lower in
HRT users than non-users (27(1.00%) vs 141(1.74%, p¼0.007)). HRT use for
6 months was associated with a lower risk of revision (HR 0.61 (0.41 to
0.93)) [Figure]. Both higher adherence (p¼0.007) and longer therapy
duration (p¼0.008) led to further reductions in revision rates. [Table].Sensitivity analyses: effect of adherence and cumulative use of HRT on implant surv
Exposure N (%)
HRT MPR Non-user 8,100 (75.0%)
< 0.4 1,631 (15.1%)
0.4 to < 0.8 594 (5.5%)
 0.8 475 (4.4%)
p for trend
HRT Cumulative use (DDD) Non-user 8,100 (75.0%)
<365 507 (4.7%)
365 to 1,065 1,180 (10.9%)
>1,065 1,013 (9.4%)
p for trend
ĂConclusions: HRT use for at least 6 months is associated with an up to 40%
reduction in prosthesis failure after lower limb total joint arthroplasty.
Hormone therapy for at least 1 year appeared related to further reduction
in failure rates to about 50%. This supports evidence that there is a signif-
icant protective beneﬁt of anti-resorptive drugs in patients undergoing
lower limb arthroplasty. These ﬁndings require replication in formal
randomized controlled trials.
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LATENT CLASS CLUSTER ANALYSIS SHOWS FOUR DISTINCT SUBTYPES
OF KNEE OA: DATA FROM THE OSTEOARTHRITIS INITIATIVE.
J.H. Waarsing, S.M. Bierma-Zeinstra, H. Weinans. Erasmus MC, Rotterdam,
Netherlands
Purpose: A possible explanation for the seeming complexity of osteoar-
thritis is that it is not one disease, but a collection of disease sub-types with
different aetiology and clinical characteristics. In this study we used latent
class cluster analysis to ﬁnd subtypes of knee osteoarthritis based on OA
characteristics in the baseline data of the Osteoarthritis Initiative (OAI).
Methods: Latent class cluster analysis (LCA) is a model based clustering
approach that assumes the existence of a latent variable (the various
clusters) that inﬂuences a set of observed variables, in this case OA char-
acteristics. The optimal number of clusters was determined based on the
BIC (Bayesian Information Criterion) that informs on the goodness of ﬁt of
the model, and the AWE (ApproximateWeight of Evidence) which informs
on the ability to classify subjects into the various clusters.
The OA characteristics that served as input for the LCA was formed by the
set of x-ray scores of different features, quantitative MRI cartilage
measures and various clinical scores like WOMAC and VAS from 520
subjects of the OAI progression cohort at baseline.
Since OA increases in severity over time, a cluster analysis can only be
meaningful when performed independent of disease severity. To accom-
plish this we included a severity variable into the model, such that a model
ﬁt was obtained adjusted for severity. The severity variable was obtained
by performing Latent Class Factor analysis, which is similar to principle
component analysis, but works for both continuous and categorical data.
The same set of OA characteristics was used as input.
Results:Ourmethod resulted in 4 clusters, of which the 1st contained 47% of
the subjects, the2nd27%, the 3rd15%and the4th12%of the subjects. Clusters
1, 2 and 4 showed mainly medial cartilage degeneration, while cartilage
degeneration in the 3rd clusteroccurred laterally. Interestingly, clusters 3 and
4 showed a strong increase in area of denuded bone with increasing OA
severityasmeasuredonMRI,while cluster 1 did not showanydenudedbone,
independentofOAseverity. Cluster2 showedaverymild increase indenuded
bone areawith increasing OA severity. Pain scores increased with increasing
severity in all clusters. Pain scores were lower in the 3rd cluster, signiﬁcantly
so in the VAS scores reﬂecting pain in the last month (p<0.05).
We further examined if there were difference in the presence of risk-
factors between the clusters. There were no differences in the presence of
heberden's nodes or BMI. However, clusters varied with respect to repor-
ted trauma. Prevalence of traumawas lowest in cluster 1 (33%) and highest
in cluster 4 (56%).
Finally, using the x-ray scores at 48 months, we looked at differences in
progression, characterized by the prevalence of subjects that increased inival
Failure incidence (/1,000 py) [95%CI] HR [95%CI]; p-val
4.25 [3.61 to 5.02] REFERENCE
3.04 [1.94 to 4.76] 0.70 [0.44 to 1.14]; p¼0.15
2.98 [1.34 to 6.63] 0.66 [0.29 to 1.50]; p¼0.33
0.97 [0.24 to 3.86] 0.22 [0.05 to 0.89]; p¼0.033
0.007
4.25 [3.61 to 5.02] REFERENCE
5.24 [2.73 to 10.07] 1.23 [0.63 to 2.42]; p¼0.54
1.74 [0.83 to 3.65] 0.40 [0.19 to 0.86]; p¼0.019
2.39 [1.33 to 4.32] 0.53 [0.29 to 0.99]; p¼0.046
0.008
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the various clusters. Medial progression occurred only in clusters 1, 2 and
4, most dramatically so in cluster 4 (48%). Cluster 3 again only showed
lateral progression (61%).
Conclusions: We found clear differences between the various clusters.
Cluster 1 could be described as amild type of OA,with nodenuded bone and
limited OA progression. Cluster 3 and 4weremore severe and erosive types
of OA, showing strong increases in area of denudedbonewith increasingOA
severity, and a high prevalence of progression. Interestingly, cluster 3 was
purely a lateral type of OA, while cluster 4was purelymedial in all respects.
The causes that led to differences between the clusters remain speculative.
The higher prevalence of reported trauma in cluster 3 and 4, the more
aggressive OA types might suggest a difference in OA initiation.
Wekept the complexityof themodels lowtoreduce the riskofoverﬁttingand
increase the likelihood that our ﬁndings are generalizable to other cohorts.
The fact that clusters also differed on data not included in cluster ﬁnding
(trauma and progression) indicates that the found clusters are meaningful.
In conclusion, latent class cluster analysis conﬁrmed the suspected exis-
tence of distinct subtypes of knee OA.
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INADEQUATE PAIN RELIEF (IPR) IN KNEE OSTEOARTHRITIS: WHAT
DOES IT LOOK LIKE? A EUROPEAN SURVEY OF OSTEOARTHRITIS REAL
WORLD THERAPIES (SORT)
P. Conaghan 1, F. Rannou 2, N. Arden 3, S.V. Everett 4, R. Balshaw 5,
P.M. Peloso 4, D.J. Watson 4, S.S. Sen 4, S.D. Taylor 4. 1Univ. of Leeds, Leeds,
United Kingdom; 2Cochin Hosp., Univ. Paris Descartes, Paris, France; 3Univ.
of Oxford, Oxford, United Kingdom; 4Merck, Sharp & Dohme, Corp.,
Whitehouse Station, NJ, USA; 5 Syreon Corp., Vancouver, BC, Canada
Purpose: Osteoarthritis (OA) treatment is often unsatisfactory, with
limited data suggesting that inadequate pain relief (IPR) is a major issue for
people with OA. Despite multiple medication options, data on treatment
patterns, adequacy of pain relief and quality of life are limited. SORT was
designed to determine the adequacy of pain relief and compare clinical
characteristics and patient-reported outcomes in patients with knee OA.
Methods: SORT, a 12-month prospective, observational study enrolled
1,260 participants (across 6 EU countries) who used oral and/or topical
agents. People > 50 years old with knee OA visiting a primary care
physician and taking pain medications in the past 14 days were enrolled.
Clinical history, medications, quality of life, treatment satisfaction and
health care resource utilization were collected at baseline and months 1, 3,
6, 9 and 12. IPR was deﬁned as an average Brief Pain Inventory pain score of
"moderate or greater pain" (score >4). Baseline data are presented in this
analysis.
Results: Evaluable baseline data are presented for 1025 participants: 68%
women; median age 67 years; duration of knee OA for 5.5 years (SD¼6.2)and 67% were taking oral pain medications, 14% were taking topical or
a combination of oral and topical agents. Hypertension (50%) was the most
common co-morbidity. IPR was reported by 54% of the cohort (558 of
1025). Participants reporting IPR were clinically different than non-IPR
participants having greater BMI (30.3 vs. 28.7 kg/m2, p< 0.001); duration
of disease (6.2 yrs vs. 4.8yrs, p <0.001) and proportion with OA of both
knees (55% vs. 39%, p<0.001). Overall, the analgesics used most oftenwere
NSAIDs (64.1%); followed by paracetamol (39.8%), medications containing
opioids (20.2%) and alternative therapies (12.6%). IPR participants (vs. non-
IPR) used more opioid containing medications (24.7% vs. 14.8%, p< 0.001).
IPR participants (vs. non-IPR) differed in their scoring on: WOMAC Stiff-
ness (115 vs. 67, p< 0.001), Pain (266 vs. 136, p< 0.001), Physical Function
(892 vs. 459, p<0.001); SF-12 General Health (fair/poor 47% vs. 27%,
p<0.001); satisfaction with prescribed knee OA treatment (less than
satisﬁed 59% vs. 36%, p<0.001) and satisfactionwith treatment side effects
(less than satisﬁed 41% vs. 23%, p<0.001). Additionally, there were
signiﬁcant differences in IPR participants' report of response to prescribed
medication (fair, poor and no response 67% vs. 43%, p<0.001) as compared
to non-IPR. IPR vs. non-IPR participants differed signiﬁcantly in the
number of GP/family physician visits for knee OA (p<0.023) and number of
physician visits for other reasons (p<0.011). More IPR participants repor-
ted having "more than one visit" to a physician for knee OA and other
reasons than non-IPR participants.
Conclusions: SORT, an observation of real world clinical practice, found
over half of those being treated for knee OA had persistent moderate to
severe pain. IPR was associated with higher BMI, longer disease duration,
multiple site OA, greater opioid use and more health-care resource utili-
zation.
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BODYWEIGHT CHANGES AND CORRESPONDING CHANGES IN PAIN AND
FUNCTION IN PERSONS WITH SYMPTOMATIC KNEE OSTEOARTHRITIS.
A LONGITUDINAL ANALYSIS USING DATA FROM OAI AND MOST
D.L. Riddle 1, P.W. Stratford 2. 1Virginia Commonwealth Univ., Richmond, VA,
USA; 2McMaster Univ., Hamilton, ON, Canada
Purpose: Osteoarthritis (OA) of the knee has multiple causes but one of the
more powerful risk factors for OA onset and progression is excessive
bodyweight. We found no studies that determined if a dose-response
relationship existed between bodyweight changes, both gains and losses,
and changes in knee related pain and functional status in a large sample of
persons with symptomatic knee osteoarthritis. Trial evidence suggests that
weight loss of at least 5% of body weight would lead to improved function
and that weight losses of 10% or more would lead to greater reductions in
pain and substantially improved function. Recommendations based on
trial ﬁndings on persons with knee OA are similar to federal government-
based recommendations for weight loss to optimize health. The purpose of
our study was to determine if a dose-response relationship exists between
percentage bodyweight changes in persons with symptomatic knee oste-
oarthritis (OA) and self reported pain and function.
Methods: Data from persons in the Osteoarthritis Initiative (OAI) and the
Multicenter Osteoarthritis (MOST) datasets (n¼1410) with symptomatic
function limiting knee OAwere studied. For the OAI, we used baseline and
3-year follow-up data while for the MOST, baseline and 30-month data
were used. Key outcome variables were WOMAC Physical Function and
Pain change scores. In addition to covariates, the predictor variable of
interest was the extent of weight change over the study period and divided
into 5 categories representing different percentages of bodyweight
change.
Results: A signiﬁcant dose-response relationship (p< 0.001) was found
between the extent of percentage change in bodyweight and the extent of
change in WOMAC Physical Function and WOMAC Pain. For example,
persons who gained >10% of bodyweight had WOMAC Physical Function
score changes of -5.4 (95%CI, -8.7, -2.00) points indicating worsening
relative to the reference group of persons with weight changes of between
<5% weight gain and <5% weight loss.
Conclusions: Our data provide the ﬁrst published evidence to suggest
a dose-response relationship between changes in bodyweight and corre-
sponding changes in pain and function. The threshold for this response
gradient appears to be >10% bodyweight shifts. Clinicians can advise
